• June 16-19, 2025
  • Boston Convention & Exhibition Center

Virpax Pharmaceuticals, Inc.

Loading

Virpax Pharmaceuticals, Inc.

Monday, June 03, 2024
Company Presentation
Pain Management
Company Presentation Theater 3
Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications.
Virpax Pharmaceuticals, Inc.
Company Website: https://virpaxpharma.com/
Lead Product in Development: Probudur- A next generation liposomal bupivacaine formulation that has demonstrated 96 hours pain control after administering a single injection at the wound site in animal studies.
Number Of Unlicensed Products (For Which You Are Seeking Partners): 5

Exchange

NASDAQ

Ticker

VRPX

Company HQ City

Berwyn

Company HQ State

PA

Company HQ Country

United States

CEO/Top Company Official

Gerald W. Bruce

Development Phase of Primary Product

Pre-Clinical
Speakers
Gerald Bruce, BA
Chief Executive Officer
Virpax Pharmaceuticals Inc.
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS